Polpharma Biologics

At Polpharma Biologics, we're all about pushing the boundaries in the biosimilar industry! Every year, we dive deep into market trends, conduct thorough clinical evaluations, and leverage our top-notch development and manufacturing capabilities to choose the best biosimilar candidates. 🔝 What sets us apart is our comprehensive approach. We place a strong emphasis on detailed market analysis, which allows us to identify needs and gaps in the market. This enables us to strategically develop biosimilars that meet the highest standards of quality and efficacy. 💪 A big shoutout to Łukasz Żemło, our Head of Commercial Operations, and incredible BD team for leading the charge in making high-quality, affordable biosimilars accessible to patients and healthcare providers around the globe. Their dedication and expertise are key to our success in bringing innovative healthcare solutions to the market. 🌏 #Biosimilars #Commercial #PolpharmaBiologics #AdvancingHealthcare

In the latest issue of the magazine Kierunek Farmacja, Dr Adriana Kiędzierska - Mencfeld discusses the development of the first Polish monoclonal antibody – biosimilar natalizumab and what a milestone achievement it constitutes for the Polish biotech sector. 🧬 As she says: "This success opens up opportunities for many companies in the Polish biotechnology sector to find commercial partners, collaborators, and high-class specialists. It's a signal to Europe and the USA that it's worth paying attention to Poland, its scientists, experts, and companies that are meeting the expectations of the global market." 🌐 You can read the article here ⬇️  https://bit.ly/4dSSAaE [Article available in Polish] #Biotechnology #Biosimilars #PolishScience #Innovation #PharmaceuticalResearch #ScientificDevelopment 

Networking done right at CPHI Milan! 🤝 We showcased Polpharma Biologics' global presence in biosimilar medicines, connected with partners, forged new partnerships, and explored exciting opportunities. Hear from our Chief Business Officer, Hannes Teissl, on our experience at this year's event. Let's continue this momentum together and shape the future of biosimilars. 🧬 See you at the next bio fairs! #CPhI2024 #networking #businessgrowth

The inauguration of the 2024/2025 academic year at Szkoła Główna Gospodarstwa Wiejskiego w Warszawie is a special moment for students and the entire academic community. This year, we took an active role in the event 🎉 The program included, among other highlights, an inaugural lecture by Professor Michał Kwiatek. A key highlight of the event was the ceremony for the presentation of awards and distinctions to students, which were funded by us and other partners of the faculty. Polpharma Biologics is proud to support the Faculty of Biology and Biotechnology, contributing to shaping future generations of scientists 👩🔬 👨🔬 Your passion and dedication inspire us to continue our collaboration at the highest level. #PolpharmaBiologics #AcademicExcellence #FutureLeaders #SGGW #Biology #Biotechnology

Our team had a fantastic second day at CPHI Milan! 👏 Thanks to everyone who visited our booth and learned more about our biosimilars pipeline. 📢 Don't miss out on the last day to connect with us at booth 3F106!

Day 1 at CPHI Milan is in the books! 📚 Polpharma Biologics team had a fantastic time connecting with industry leaders and presenting our highly attractive portfolio of well-selected biosimilar products. We’re excited to continue exploring new opportunities and forging partnerships that will help us deliver life-changing therapies to patients around the world. Don't miss the opportunity to visit our booth today 3F106 to learn more about our attractive pipeline! #CPhI2024 #PolpharmaBiologics #Biosimilars

Are you at CPHI Milan and interested in exploring career growth opportunities with Polpharma Biologics? 👩🦰👨 Stop by our booth 3F106 and chat with Alicja Kryczalo-Lara, MBA, Head of Talent Attraction. We offer a variety of career development paths across our company. Don't miss this chance to learn more. We are waiting here for you! #cphi2024 #PolpharmaBiologics

We are ready for CPhI!!! Meet this wonderfull team at the booth 3F106 and check Polpharma Biologics attractive biosimilars pipeline! Looking forward to these 3 exciting days! #cphi2024 #PolpharmaBiologics

Recently Rafał Derlacz – Technical Project Management Director at Polpharma Biologics – joined the group of experts delivering lectures as part of the Practical Biotechnology Course organized by the Medical Research Agency (Agencja Badań Medycznych)! The aim of the course is to educate and deepen participants' knowledge of biotechnology in a practical approach. During his presentation, Rafał discussed the development and registration of the first Polish biosimilar monoclonal antibody – natalizumab. His lecture covered topics such as: 🔬the mechanism of action of natalizumab  🧪the development history of the biosimilar natalizumab ⚙️optimization of the manufacturing process  💊development of the drug formulation  📝clinical trial strategy See you during future initiatives! #Biotechnology #ABM #PolpharmaBiologics #Natalizumab #BiotechEducation #Biosimilars

🏃♂️ The Warsaw Centennial Marathon got the city moving! 🏃♀️ Last Sunday, a unique event took place – the 100th Warsaw Marathon, and we, as a team from Polpharma Biologics, were there in full force! 🎉 20 people from our company lined up at the start, over two distances (42,195 or 10 km), conquering the streets of Warsaw.   Each of us was not only racing for our own result, but also pushing our limits and, above all, having a great time! 💪 A huge congratulations to everyone who took part – both runners and supporters. It was an unforgettable day filled with energy! 🙌 #PolpharmaBiologics #WarsawMarathon #teamwork #running #goals